The paper reviews developments in the EU competition practice approach to “reverse payment agreements”. These are settlements that involve a payment (in direct or indirect form) flowing in a direction that intuitively appears “reverse”, as money is paid by the patent holder (the originator) to the alleged infringer – a generic firm.
Parcu, P.L., Rossi, M.A. (2011). Reverse Payment Settlements in the Pharmaceutical Sector: A European Perspective. EUROPEAN JOURNAL OF RISK REGULATION, 2, 260-262.
Reverse Payment Settlements in the Pharmaceutical Sector: A European Perspective
ROSSI, MARIA ALESSANDRA
2011-01-01
Abstract
The paper reviews developments in the EU competition practice approach to “reverse payment agreements”. These are settlements that involve a payment (in direct or indirect form) flowing in a direction that intuitively appears “reverse”, as money is paid by the patent holder (the originator) to the alleged infringer – a generic firm.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
1_pub_su_rivista.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
84.08 kB
Formato
Adobe PDF
|
84.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/36981
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo